Studies examining the efficacy of GLP-1 drugs used for weight loss have generally quantified changes in fat and lean mass, with changes in lean mass serving as a surrogate for muscle mass
However, there is a gap in knowledge as to understanding whether once weekly semaglutide would lead to reductions in symptoms and physical limitations and to improved exercise function, in addition to weight loss, in patients with heart failure with preserved ejection fraction and obesity
While you may be able to take semaglutide with other prescription medications, GLP-1 medicines may impact the effects of some prescriptions, including medications for thyroid conditions, medicines that contain insulin, and sulfonylureas
That's why our program includes long-term maintenance planning and some patients choose to continue a lower maintenance dose for ongoing support
The FDA simultaneously launched a dedicated compliance webpage for telehealth companies promoting compounded drugs, signaling this is now a sustained priority - not a one-time action